Digital healthcare is changing far more than how patients order prescriptions or speak with a doctor online. Telehealth platforms, remote monitoring, health data and connected care services now influence how patients find treatment, receive medication and manage their health over time.
For pharmaceutical companies, this creates a new challenge. They are no longer the only companies guiding the patient journey. Digital health platforms now sit between drugmakers, healthcare providers, pharmacies and patients.
For founders, that change opens new opportunities.
This guide discusses how the pharmaceutical industry is adapting to digital healthcare. It explores what healthcare startups can learn from pharma’s transformation, where new gaps are emerging and how startup founders can build services that support patients across the care journey.
Highlights
- Digital healthcare is expanding pharma’s role beyond medication into telehealth, remote monitoring, patient support and connected care.
- Telehealth platforms are changing how patients access treatments and where influence sits across the care journey.
- Remote monitoring, healthcare data and AI are creating new opportunities for startups to support care between appointments.
- Startups can create value by connecting patients, clinicians, pharmacies and pharmaceutical companies without replacing them.
Build Your Business. Get Grant Ready.
Take free expert-led courses and unlock access to tools, mentorship, networking, and Verizon grant opportunities for small businesses.
We earn a commission if you make a purchase, at no additional cost to you.
Take free expert-led courses and unlock access to tools, mentorship, networking, and Verizon grant opportunities for small businesses.
From Drug Manufacturer to Digital Healthcare Partner
Pharmaceutical companies have long focused on developing, marketing and distributing medication. Digital healthcare is expanding that model.
The patient experience can now include digital support before, during and after treatment.
Care Now Extends Beyond the Medication
Digital patient support, virtual care, digital therapeutics and adherence tools are becoming part of connected healthcare services. This gives patients more ways to access care and stay engaged with treatment.
Expectations have changed, too. Patients increasingly want healthcare they can access online from the first interaction. They also expect that access to continue through treatment and follow-up.
Digital healthcare is moving beyond informational portals toward end-to-end care journeys. PrEP online is a clear example. A digital model can deliver eligibility screening, clinician consultation, prescription coordination and follow-up. This can improve access to preventive medication while maintaining clinical oversight.
This creates room for startups to solve more than one gap in the patient journey. Instead of adding another standalone healthcare tool, they can connect several parts of the experience. That could mean helping patients move from their first interaction to treatment and follow-up through one digital model.
Telehealth Is Changing Who Owns the Patient Relationship
Telehealth platforms are becoming a key connection point in healthcare. They’re helping patients find care and making treatment easier to access.
People may now discover a treatment through a digital platform rather than through channels tied to the drug manufacturer. The platform can then connect that patient with a clinician and pharmacy. As a result, the manufacturer has less direct influence over how some medications reach patients.
This is even more visible with older generic drugs, where manufacturers may have less influence than they do over patented products.
For example, phentermine has been approved since 1959 and is available from several manufacturers as a generic tablet. Telehealth platforms now provide another route for patients to access it alongside traditional clinic visits.
This means online doctors who prescribe phentermine can become a key point of influence between the manufacturer and the patient, reducing the manufacturer’s direct role in how some patients encounter the drug.
Compounding pharmacies add another layer of competition. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before marketing. That means approved manufacturers may operate alongside compounded versions they do not make or control.
Digital channels haven’t just changed how prescriptions are written for these products. They have also moved the point of influence outside the companies that make the drugs.
Remote Monitoring Extends Care Beyond the Appointment
Telehealth made it possible to move many appointments online. But healthcare is moving beyond one-time video visits. Remote monitoring can extend care into the days and weeks between appointments.
Connected devices and patient-reported data give providers information about what is happening outside the clinic. Monitoring systems can collect that information, flag changes through alerts and help clinical teams decide when follow-up may be needed.
Digital care does not end when a video visit closes. A remote healthcare monitoring platform can:
- Collect patient data between appointments
- Route relevant alerts to clinical teams
- Support ongoing follow-up workflows
For startups, the challenge is not simply collecting more patient information. The product also has to determine what information is useful, who needs to see it and what should happen when a meaningful change appears. A monitoring tool that generates alerts without fitting into existing clinical workflows can create more work instead of reducing it.
That makes workflow design an important part of the product itself. Founders need to think about how data moves from the patient to the platform, how it reaches the right clinical team and how follow-up is documented once someone acts on it.
They also need to distinguish between information that requires attention and information that can simply be recorded for later review. The value of remote monitoring comes from supporting decisions and follow-up, not from collecting the largest possible volume of data.
Together, these functions can help providers detect changes earlier and manage chronic conditions between scheduled visits.
Data and AI Are Reshaping Pharmaceutical Decision-Making
Digital healthcare is also giving pharmaceutical companies access to new kinds of data. Along with AI, that data can support decisions across drug development, clinical trials, patient identification, treatment support and pharmacovigilance.
The regulatory side is evolving alongside those capabilities. The FDA has issued draft guidance covering AI models used to support regulatory decision-making related to drug safety, effectiveness and quality.
For startups working with pharmaceutical companies, that makes data reliability more than a technical issue. The way information is collected, validated and used can affect whether an AI-supported workflow is useful in a regulated environment.
Digital platforms can also reveal more about what happens during a patient’s treatment journey. They can capture information about patient behavior that traditional pharmaceutical channels could not access as easily. This gives pharma companies another source of insight when developing treatments and supporting patients.
But collecting more data also creates more responsibility. Patient information needs strong privacy and security protections. Data quality is just as important. Poor data can limit the value of the systems built around it, and healthcare companies also need to meet regulatory requirements.
If you’re building a healthcare startup in this space, these safeguards need to be part of the foundation. Privacy, security, data quality and regulatory compliance should guide how you build your system from the start. Addressing them early also keeps compliance from becoming a problem you have to solve as your company grows.
The Biggest Opportunities May Sit Between Existing Healthcare Services
Healthcare startups don’t always need to create a new treatment or replace an existing provider. Some opportunities come from improving how existing parts of healthcare work together.
Think about the patient journey. A patient may interact with a digital platform, clinician, pharmacy, monitoring service and pharmaceutical product as part of the same treatment experience. Each serves a different purpose. The challenge is helping the patient move between them without creating more friction.
That gives founders another way to look for startup ideas. Instead of asking what healthcare product is missing, you can ask where the connections break down.
That might mean:
- Improving how patients move from consultation to treatment
- Helping healthcare systems exchange data
- Supporting follow-up after care has started
Pharma’s digital transformation makes these gaps easier to see. As more parts of care become digital, the companies that make those connections work can become an important part of the healthcare experience, even when they don’t provide the treatment themselves.
What Pharma’s Digital Transformation Means for Healthcare Startups
For healthcare founders, the practical question is how to build around those gaps without creating another disconnected tool. The strongest opportunities make it easier for patients and providers to move through the existing healthcare system.
Build Around the Patient Journey
A standalone tool may solve one problem. But patients often need support across several steps, from finding care to accessing treatment and staying connected afterward.
For startups, that creates opportunities to build around:
- End-to-end patient journeys
- Patient access and convenience
- Continuous monitoring and follow-up
You can also build the infrastructure that connects clinicians, patients, pharmacies and pharmaceutical companies. Your startup then becomes part of the digital layer around existing healthcare products. Instead of making the drug or providing the clinical care, you make it easier for those parts of healthcare to connect with the people who need them.
Make Data Work Across the Experience
There’s also an opportunity to help healthcare data move between systems. As digital care involves more platforms and providers, those systems need to exchange useful information. Data interoperability can help connect those parts of the healthcare experience.
The same principle applies when data moves across organizations. A patient may interact with several systems during one treatment journey, but those systems do not automatically share information in a useful way. For a startup, interoperability therefore affects more than technical integration.
It can shape whether clinicians have enough context to make decisions, whether patients have to repeat information at each step and whether follow-up information reaches the next provider involved in care.
Building around clear data flows, defined responsibilities and consistent records can help the product support the wider care journey rather than becoming another isolated layer. Each integration should solve a specific handoff problem rather than simply add another data source.
AI creates another opportunity, but it also raises the bar for how you handle healthcare data. If you use AI in your product, responsible use needs to come first. That means working with reliable data while keeping privacy and regulatory requirements in view.
These opportunities come with limits. You may want to move fast and make your product easy to use, but healthcare requires a more cautious approach. Clinical oversight, regulation, privacy and patient safety still need to guide what you build and how you bring it to patients.
Digital Healthcare Is Redefining Pharma’s Role
The pharmaceutical industry is adapting to digital healthcare across much of the patient experience. Telehealth and connected patient journeys are changing how people access treatment. Remote monitoring keeps care going between appointments, while data and AI support new ways to understand patients and make healthcare decisions.
Digital transformation is also changing where influence sits within healthcare. Pharmaceutical companies may make the medication, but digital platforms help patients find care, connect with providers and access treatment.
That creates a different kind of opportunity for healthcare startups. You don’t have to replace pharmaceutical companies, pharmacies or providers. You can connect them and make the patient journey easier to navigate.
If you’re building around these gaps, explore StartupNation for practical guidance on starting and growing a business.
FAQs
How Is Digital Healthcare Changing the Pharmaceutical Industry?
Digital healthcare is changing how pharmaceutical companies connect with patients and providers. Telehealth, remote monitoring, connected patient journeys, data and AI are creating new ways to support treatment while giving digital platforms more influence over the patient experience.
What Opportunities Does Digital Healthcare Create for Startups?
Healthcare startups can strengthen connections among patients, clinicians, pharmacies and pharmaceutical companies. Opportunities include end-to-end patient journeys, easier access to treatment, remote monitoring, data interoperability and digital infrastructure that supports care before and after appointments.
Do Healthcare Startups Need to Compete With Pharmaceutical Companies?
No. Startups can create value without developing medications or replacing pharmaceutical companies. They can build the digital services and infrastructure that connect existing treatments with patients and providers while making healthcare easier to access and navigate.
Image by Drazen Zigic on Magnific
